Dilated heart disease
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Dilated Cardiomyopathy: An Overview
Introduction to Dilated Cardiomyopathy (DCM)
Dilated cardiomyopathy (DCM) is a condition characterized by the enlargement and impaired contraction of the heart's ventricles, primarily the left ventricle, without an underlying ischemic cause such as coronary artery disease . This condition leads to systolic dysfunction, where the heart's ability to pump blood is compromised, often resulting in heart failure and other severe complications .
Genetic and Nongenetic Causes
Genetic Factors
A significant proportion of DCM cases are attributed to genetic mutations. Approximately 30-60% of DCM cases are familial, involving mutations in over 60 genes that encode various myocyte proteins, including those in the sarcomere and desmosome . The most commonly implicated gene is TTN, which encodes the protein titin. Familial DCM (FDC) is often inherited in an autosomal dominant pattern, but X-linked and mitochondrial inheritance patterns have also been observed .
Nongenetic Factors
Nongenetic causes of DCM include myocarditis (often viral), exposure to toxins such as alcohol and certain drugs, and systemic conditions like endocrine or autoimmune diseases . These factors can lead to inflammation and damage to the myocardium, contributing to the development of DCM .
Clinical Presentation and Diagnosis
Symptoms and Complications
Patients with DCM typically present with symptoms of systolic heart failure, such as shortness of breath, fatigue, and fluid retention. As the disease progresses, diastolic dysfunction and right ventricular impairment may also occur . Complications include arrhythmias, thromboembolic events, and cardiogenic shock, which can lead to sudden cardiac death .
Diagnostic Approaches
Diagnosis of DCM involves a combination of imaging techniques, such as echocardiography and cardiac magnetic resonance imaging (MRI), to assess ventricular size and function . Endomyocardial biopsy may be performed to identify underlying inflammatory or infectious causes. Genetic testing and family screening are crucial for identifying familial cases and enabling early intervention .
Treatment Strategies
Medical Management
The primary treatment for DCM focuses on managing heart failure symptoms and preventing complications. This includes the use of guideline-based heart failure medications such as beta-blockers, ACE inhibitors, and diuretics . Lifestyle modifications, including salt and fluid restriction, moderate exercise, and avoidance of alcohol, are also recommended.
Device Therapy
In cases of severe heart failure or life-threatening arrhythmias, device therapy may be necessary. This includes cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death . For patients with end-stage heart failure, left ventricular assist devices (LVADs) or heart transplantation may be required .
Conclusion
Dilated cardiomyopathy is a complex and heterogeneous condition with both genetic and nongenetic causes. Early diagnosis through imaging and genetic testing, along with personalized treatment strategies, can significantly improve patient outcomes. Ongoing research into the genetic basis and pathophysiology of DCM holds promise for the development of more targeted therapies in the future.
Sources and full results
Most relevant research papers on this topic